Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis

Europace

Volumn 11, Issue 3, 2009, Pages 289-296

  Rolf, Sascha ^a,b   Haverkamp, Wilhelm ^a   Borggrefe, Martin ^c   Breithardt, Guenter ^b   Bocker, Dirk ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Electrophysiologic study; Idiopathic dilated cardiomyopathy; Implantable cardioverter defibrillator; Programmed ventricular stimulation; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IDIOPATHIC DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SUDDEN DEATH; SURVIVAL; TACHYCARDIA;

CARDIOMYOPATHIES; CLINICAL TRIALS AS TOPIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RECURRENCE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 61649093313     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun330     Document Type: Article

References (28)

1. Buxton AE, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME. Non-sustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Circulation 1987;75:1178-85.
2. Rinaldi CA, Simon RD, Baszko A, Bostock J, Elliot D, Bucknall C et al. Can we predict which patients with implantable cardioverter defibrillators receive appropriate shock therapy? A study of 155 patients. Int J Cardiol 2003;88:69-75.
3. Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 1998;32:739-45.
4. Chen X, Shenasa M, Borggrefe M, Block M, Hindricks G, Martinez-Rubio A et al. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J 1994;15:76-82.
5. Constantin L, Martins JB, Kienzle MG, Brownstein SL, Mccue ML, Hopson RC. Induced sustained ventricular-tachycardia in nonischemic dilated cardiomyopathy - dependence on clinical presentation and response to antiarrhythmic agents. Pacing Clin Electrophysiol 1989;12:776-83.
6. Milner PG, Dimarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 1988;11:562-8.
7. Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:992-7.
8. Cuesta A, Mont L, Rogel U, Valentino M, Matas M, Brugada J. Comparison of effectiveness of implantable cardioverter defibrillator in patients with idiopathic dilated cardiomyopathy versus those with proved coronary heart disease. Am J Cardiol 2003;92:1227-30.
9. Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991;121:1124-31.
10. Fazio G, Veltri EP, Tomaselli G, Lewis R, Griffith LSC, Guarnieri T. Long-term follow-up of patients with nonischemic dilated cardiomyopathy and ventricular tachyarrhythmias treated with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1991;14:1905-10.
11. Rankovic V, Karha J, Passman R, Kadish AH, Goldberger JJ. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2002;89:1072-6.
12. Russo AM, Verdino R, Schorr C, Nicholas M, Dixit S, Patel V et al. Occurrence of implantable cardioverter defibrillator events in patients with syncope and a nonischemic dilated cardiomyopathy. Am J Cardiol 2001;88:1444-6.
13. Hsia HH, Marchlinski FE. Electrophysiology studies in patients with dilated cardiomyopathies. Card Electrophysiol Rev 2002;6:472-81.
14. Bourke JP, Richards DA, Ross DL, McGuire MA, Uther JB. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Am J Cardiol 1995;75:431-5.
15. Borggrefe M, Trampisch HJ, Breithardt G. Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias. J Am Coll Cardiol 1988;12:140-9.
16. Bocker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M et al. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 1993;21:1638-44.
17. Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Am J Cardiol 1987;59:291- 5.
18. Liem LB, Swerdlow CD. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988;62:611-6.
19. Grimm W, Marchlinski FE. Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and an implantable cardioverter- defibrillator. Eur Heart J 1995;16:218-22.
20. Bansch D, Bocker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000;36:566-73.
21. Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 1984;70:451-6.
22. Hook BG, Marchlinski FE. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. J Am Coll Cardiol 1991;17:985-90.
23. Germans T, van Rossum AC. The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy. Heart 2008;94:510-8.
24. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-5.
25. Bohl S, Wassmuth R, Abdel-Aty H, Rudolph A, Messroghli D, Dietz R et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 2008;24:597-607.
26. Grimm W, Hoffmann JJ, Muller HH, Maisch B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 2002;39:780-7.
27. Daubert JP, Berger RD, Ellenbogen KA, Winters SL, Schaechter A, Taylor SG et al. Induction of ventricular arrhythmia at electrophysiologic study in DEFibrillators in Non-Ischemic cardiomypathy Treatment Evaluation (DEFINITE) predicts need for implantable cardioverter defibrillator therapy. Circulation 2004;110:III-624 (abstract).
28. Naccarelli GV, Prystowsky EN, Jackman WM, Heger JJ, Rahilly GT, Zipes DP. Role of electrophysiologic testing in managing patients who have ventricular-tachycardia unrelated to coronary-artery disease. Am J Cardiol 1982;50:165-71.